Status
Conditions
Treatments
About
The aim of this study is to improve knowledge of natural history and methods of monitoring the evolution of Glycogen storage disease type III regarding the muscle and to study the prospective approach of large series of patients, and using the same protocol for the follow up of the children and adults.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
Loading...
Central trial contact
Pascal Laforet, MD; Pierre Carlier, MD, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal